Daily Media Digest November 7, 2017
Health Canada Approves IMFINZI® (durvalumab) for Previously Treated Patients with Advanced … Canada NewsWire (press release) “6, 2017 /CNW/ – AstraZeneca Canada today announced that Health Canada has approved Imfinzi® (durvalumab) for the treatment of […]